Shares of Regeneron Pharmaceuticals, Inc. REGN have gained 13.5% in the year so far against the industry’s decline of 2.8%.

The stock's rise snapped a five-day losing streak.

For the biopharma industry to match the pace of genomic innovations and speed new therapies to market, it will need to ...

Symptoms and activity improved in patients with chronic obstructive pulmonary disease and type 2 inflammation.

Ebglyss' approval highlights the opportunity that exists in the AD space, and may have potential advantages in efficacy and ...

Intellia Therapeutics, Inc. NTLA announced that it has initiated the pivotal phase III HAELO study evaluating NTLA-2002 for ...

Ana Baramidze, MD, PhD, discussed 5-year follow-up results from the EMPOWER-Lung study evaluating cemiplimab vs chemotherapy ...

Democratic Vice President Kamala Harris led Republican Donald Trump by a marginal three percentage points - 46% to 43% - as the two remain locked in a close race to win the Nov. 5 U.S ...

Israel’s air attacks against Hezbollah continued, and it said parts of a fourth military division had begun operating against the militant group in southwestern Lebanon. Much of Gaza has been de ...

Kamala Harris during a Tuesday appearance on “The View” is expected to announce a new policy aimed at helping families care for aging seniors. The vice president will propose establishing a ...

Poll Finds Harris Rising as She Challenges Trump on Change A national Times/Siena poll found Kamala Harris narrowly leading Donald Trump. Voters were more likely to see her, not Mr. Trump, as a ...